RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 116 filers reported holding RAPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,000 | +20.3% | 4,278 | +35.2% | 0.00% | – |
| Q2 2023 | $59,000 | +90.3% | 3,164 | +87.8% | 0.00% | – |
| Q1 2023 | $31,000 | -47.5% | 1,685 | -43.7% | 0.00% | – |
| Q4 2022 | $59,000 | +637.5% | 2,994 | +844.5% | 0.00% | – |
| Q3 2022 | $8,000 | +166.7% | 317 | +115.6% | 0.00% | – |
| Q2 2022 | $3,000 | -89.7% | 147 | -88.8% | 0.00% | – |
| Q1 2022 | $29,000 | -82.3% | 1,309 | -70.8% | 0.00% | – |
| Q4 2021 | $164,000 | +198.2% | 4,478 | +151.0% | 0.00% | – |
| Q3 2021 | $55,000 | +41.0% | 1,784 | +45.0% | 0.00% | – |
| Q2 2021 | $39,000 | +178.6% | 1,230 | +89.2% | 0.00% | – |
| Q1 2021 | $14,000 | +75.0% | 650 | +75.2% | 0.00% | – |
| Q4 2020 | $8,000 | – | 371 | +2373.3% | 0.00% | – |
| Q3 2020 | $0 | – | 15 | +150.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 6 | -98.8% | 0.00% | – |
| Q1 2020 | $11,000 | +266.7% | 510 | +405.0% | 0.00% | – |
| Q4 2019 | $3,000 | – | 101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |